Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report (2016)
Chapter: Appendix A: Committee Meeting 1 Agenda
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
4 Conclusion
A
Next Chapter: Appendix B: Committee Meeting 2 Agenda
Suggested Citation:
"Appendix A: Committee Meeting 1 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
A
Committee Meeting 1 Agenda
COMMITTEE ON A NATIONAL STRATEGY FOR THE ELIMINATION OF HEPATITIS B AND C
The Keck Center, 500 Fifth Street NW
Washington, DC 20001
November 30, 2015
Room 105
THE CHARGE TO THE COMMITTEE AND PHASE 1 REPORT
| 10:45-11:30 | The Charge to the Committee John Ward, Director, Office of Viral Hepatitis, Centers for Disease Control and Prevention Nadine Gracia, Deputy Assistant Secretary for Minority Health and Director, Office of Minority Health, Department of Health and Human Services |
| 11:30-12:00 | Study Timeline Brian Strom, Committee Chair |
| 12:00-1:00 | Lunch |
Suggested Citation:
"Appendix A: Committee Meeting 1 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
OVERVIEW OF HBV AND LOGISTICAL AND SOCIAL ASPECTS OF ELIMINATION
| 1:00-1:30 | Overview of Epidemiology and Natural History of Hepatitis B Jules Dienstag, Carl W. Walter Professor Medicine, Massachusetts General Hospital |
| 1:30-2:00 | Gaps in Hepatitis B Monitoring and Screening Mandana Khalili, Professor of Clinical Medicine, University of California, San Francisco |
| 2:00-2:30 | The Costs and Logistics of Community HBV Screening Programs Chari Cohen, Director of Public Health, Hepatitis B Foundation |
| 2:30-2:45 | Break |
| 2:45-3:15 | The Health Systems Obstacles to Hepatitis B Elimination Robert Gish, Principal, Robert Gish Consultants, LLC |
| 3:15-3:45 | Management of the Chronic Hepatitis B Patient in Alaska Brian McMahon, Medical and Research Director, Alaska Native Tribal Health Consortium (by video) |
| 3:45-5:00 |
Panel Discussion Social and Logistical Feasibility of Eliminating HBV Art Reingold, Moderator
|
| 5:15 | Adjourn |
Suggested Citation:
"Appendix A: Committee Meeting 1 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
December 1, 2015
Room 100
SCIENTIFIC AND MEDICAL ASPECTS OF ELIMINATION
| 9:00-9:15 | Welcome and Meeting Overview Brian Strom, Committee Chair |
| 9:15-9:45 | Medical Management of Hepatitis B Anna Lok, Alice Lohrman Andrews Research Professor, University of Michigan Health System |
| 9:45-10:15 | Hepatitis B Reactivation Rohit Loomba, Professor of Medicine, University of California, San Diego |
| 10:15-10:30 | Break |
| 10:30-11:00 | Immunology of Hepatitis B Kyong-Mi Chang, Associate Chief of Staff for Research and Development, Corporal Michael J. Crescenz Veterans Affairs Medical Center |
| 11:00-11:30 | Virology of Hepatitis B T. Jake Liang, Chief of Liver Diseases Branch, Deputy Director of Translational Research, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health |
| 11:30-12:30 |
Panel Discussion Scientific and Clinical Feasibility of Eliminating HBV Randy Mayer, Moderator
|
Suggested Citation:
"Appendix A: Committee Meeting 1 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
|
|
| 12:30 | Adjourn |
Suggested Citation:
"Appendix A: Committee Meeting 1 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
Suggested Citation:
"Appendix A: Committee Meeting 1 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
Suggested Citation:
"Appendix A: Committee Meeting 1 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
Suggested Citation:
"Appendix A: Committee Meeting 1 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.